News Focus
News Focus
icon url

lemmy

08/26/14 2:19 PM

#187763 RE: corporalagarn #187757

And at a whopping Dow 30-qualifying $1.65/share!

Yeah, I agree 100%. That "no doubt" statement is truly absurd given all of the current fundamentals (and a dash of "reverse split" thrown in).
icon url

Protector

08/26/14 3:14 PM

#187773 RE: corporalagarn #187757

I IS fact the clinical trials prove it and the workings of Bavituximab have nothing to do with PPHM's market capital.

You can't make this stuff up!